Prosecution Insights
Last updated: August 17, 2026

Examiner: THUESON, HANNA MARIE

Tech Center 1600 • Art Units: 1600 1612 1638

This examiner grants 77% of resolved cases

Performance Statistics

77.3%
Allow Rate
+17.3% vs TC avg
57
Total Applications
+26.5%
Interview Lift
1283
Avg Prosecution Days
Based on 22 resolved cases, 2023–2026

Rejection Statute Breakdown

2.5%
§101 Eligibility
21.0%
§102 Novelty
61.7%
§103 Obviousness
14.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18009476 BACULOVIRUS EXPRESSION SYSTEMS Final Rejection FLAGSHIP PIONEERING INNOVATIONS V, INC.
18246279 VACCINE COMPOSITIONS FOR MUCOSAL IMMUNE RESPONSE Non-Final OA NANTCELL INC.
18569550 PRIMORDIAL GERM CELLS Non-Final OA The Regents of the University of California
18354719 METHOD FOR PRODUCING FOOD PRODUCTS USING CELLS GROWN IN CULTURE AS AN ALTERNATIVE TO ANIMAL HUSBANDRY Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18074402 ENGINEERED VASCULARIZED ORGANOIDS Non-Final OA The Regents of the University of California
17995114 Kidney Organoids Having a Nephron-like Structure and Methods of Preparing the Same Non-Final OA POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
17770463 PATIENT-MATCHED ORGANOID SYSTEMS FOR STUDYING CANCER Non-Final OA Massachusetts Institute of Technology

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month